The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...

Moderna (Nasdaq: MRNA) has secured European clearance for its latest version of Spikevax (elasomeran) for individuals aged ...

Biotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Friday before the bell. Here’s what to expect. Moderna missed analysts’ revenue expectations by 8.4% last quarter, reporting ...

There was no credible evidence that Gates has been granted approval, secret or otherwise, to spray RNA (including mRNA, a ...

July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for the updated formulation of the COVID-19 vaccine Spikevax®, ...

A new study by WashU Medicine researchers found that, in mice, histamine-releasing immune cells act as gatekeepers that protect the brain from infection.

The COVID pandemic likely began when the virus jumped from animals to humans, and didn’t start in a lab. But false narratives ...

CAMBRIDGE, MA / ACCESS Newswire / July 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its investigational mRNA therapeutics have been accepted for presentation at the ...

Corporate Counsel, in partnership with ALM Intelligence, on Monday released its 2025 General Counsel Report, an exclusive ...

The latest health updates include Centene's improved profitability forecast, US-initiated healthcare data-sharing plans ...

If you're confident that its current trials will prove successful, then this is one to buy and sit on. One word of caution ...